Overall, differences in correlations of SPARE-AD scores with molecular measures and APOE ε4 were not statistically significant, supporting the notion that the changes in approach, including regressing out brain age in SPARE-AD3, did not diminish its specificity to Alzheimer’s disease. Here, APOE is linked to early-onset autosomal dominant Alzheimer disease.